Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Xiang

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Oncoimmunology|December 18, 2012
A new dynamic model of three cell interactions for CTL responsesKhawaja Ashfaque Ahmed, Lu Wang, Jim Xiang
Biochemical and Biophysical Research Communications|January 13, 2009
CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic onesXueshu Zhang, Ross M Kedl, Jim Xiang
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Advances in dendritic cell-based vaccine of cancerXueshu Zhang, John R Gordon, Jim Xiang
Cancer Gene Therapy|May 29, 2002
Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumorsYongqing Liu, Hui Huang, Anurag Saxena, et al.
Current Medical Research and Opinion|October 7, 2006
Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infectionsMohammed M Khashab, Jim Xiang, James B Kahn
Expert Opinion on Pharmacotherapy|July 17, 2008
Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritisOrlando G Florete, Jim Xiang, Gary J Vorsanger
Current Gene Therapy|April 28, 2005
Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancerQiaohua Wu, Dajing Xia, Svein Carlsen, et al.
Cancer Research|June 3, 2005
Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responsesYongqing Liu, Xuguang Bi, Shulin Xu, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 17, 2006
Conversion of tolerogenic CD4-8- dendritic cells to immunogenic ones inducing efficient antitumor immunityXueshu Zhang, Terence Moyana, Mabood Quereshi, et al.
Molecular Immunology|June 24, 2010
LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15RZhenmin Ye, Meiqing Shi, Shulin Xu, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Oncoimmunology|December 18, 2012
A new dynamic model of three cell interactions for CTL responsesKhawaja Ashfaque Ahmed, Lu Wang, Jim Xiang
Biochemical and Biophysical Research Communications|January 13, 2009
CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic onesXueshu Zhang, Ross M Kedl, Jim Xiang
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Advances in dendritic cell-based vaccine of cancerXueshu Zhang, John R Gordon, Jim Xiang
Cancer Gene Therapy|May 29, 2002
Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumorsYongqing Liu, Hui Huang, Anurag Saxena, et al.
Current Medical Research and Opinion|October 7, 2006
Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infectionsMohammed M Khashab, Jim Xiang, James B Kahn
Expert Opinion on Pharmacotherapy|July 17, 2008
Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritisOrlando G Florete, Jim Xiang, Gary J Vorsanger
Current Gene Therapy|April 28, 2005
Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancerQiaohua Wu, Dajing Xia, Svein Carlsen, et al.
Cancer Research|June 3, 2005
Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responsesYongqing Liu, Xuguang Bi, Shulin Xu, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 17, 2006
Conversion of tolerogenic CD4-8- dendritic cells to immunogenic ones inducing efficient antitumor immunityXueshu Zhang, Terence Moyana, Mabood Quereshi, et al.
Molecular Immunology|June 24, 2010
LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15RZhenmin Ye, Meiqing Shi, Shulin Xu, et al.
Pageof 17